Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...

Operator Good morning and welcome to the UnitedHealth Group fourth quarter and full year 2024 earnings conference call. A ...

Several major drugmakers have restricted commercially insured patients from their patient assistance programs, leaving ...

No one defines these problem and their solutions better than Elizabeth Mitchell. As president and CEO of Purchaser Business Group on Health (PBGH), Mitchell leads a nonprofit coalition representing 40 ...

The middlemen who comprise a growing share of America's convoluted health care system find themselves in a bind. The public is angry about the inflated costs and opaque dealings that govern their ...

In an investor call, Andrew Witty promised full transparency and 100% pass-through rebates for prescription drugs by 2028.

The middlemen that comprise a growing share of America’s convoluted health care system find themselves in a bind. The public is angry about the inflated costs and opaque dealings that govern their ...

UnitedHealth’s net income plummeted to its lowest level since 2019 amid hefty costs, including some from the Change ...

Plus transparency around policing improves, Graze adds 3 tenants, and RIP Uecker and Lynch in today's Flyover news roundup.

Biosimilar launches achieve a 53% market share and a 53% reduction in average drug costs after 5 years of biosimilar ...